Symbiotec Pharmalab Ltd.

NSE: SYMBIOTEC | BSE: 544889 | ISIN: INE899I01028 | Industry: Pharmaceuticals
|
1102.7500 24.50 (2.27%)
NSE Sep 07, 2026 11:24 AM
Volume: 1.6M
 

1102.75
2.27%
Deven Choksey
Symbiotec operates across three interlinked platforms - steroid APIs, differentiated injectable products and fermentation-led CDMO/industrial biotechnology.
Symbiotec Pharmalab has gained 11.61% in the last 1 Week
More from Symbiotec Pharmalab Ltd.
Recommended